Co-D Therapeutics Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 3

Co-D Therapeutics General Information

Description

Operator of a preclinical stage biopharmaceutical company intended to develop combination nanomedicines with high safety profiles to treat cancer. The company's drugs are based on a polymeric micelle delivery system that eliminates toxic carriers, permits safe dose-escalation, and facilitates multi-drug delivery, enabling healthcare firms to bring to market innovative combination nano-medicines with safety profiles to treat cancer and improve patients' lives.

Contact Information

Website
www.co-drx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 821 East Washington Avenue
  • Suite 200
  • Madison, WI 53703
  • United States
+1 (608)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 821 East Washington Avenue
  • Suite 200
  • Madison, WI 53703
  • United States
+1 (608)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Co-D Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Accelerator/Incubator Completed Pre-Clinical Trials
3. Later Stage VC 08-Nov-2018 Completed Pre-Clinical Trials
2. Accelerator/Incubator Completed Startup
1. University Spin-Out 01-Jan-2012 Completed Startup
To view Co-D Therapeutics’s complete valuation and funding history, request access »

Co-D Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Co-D Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Wisconsin Economic Development Government
gBETA Accelerator/Incubator
WARF Ventures Venture Capital Minority
To view Co-D Therapeutics’s complete investors history, request access »

Co-D Therapeutics FAQs

  • When was Co-D Therapeutics founded?

    Co-D Therapeutics was founded in 2012.

  • Where is Co-D Therapeutics headquartered?

    Co-D Therapeutics is headquartered in Madison, WI.

  • What is the size of Co-D Therapeutics?

    Co-D Therapeutics has 4 total employees.

  • What industry is Co-D Therapeutics in?

    Co-D Therapeutics’s primary industry is Drug Discovery.

  • Is Co-D Therapeutics a private or public company?

    Co-D Therapeutics is a Private company.

  • What is Co-D Therapeutics’s current revenue?

    The current revenue for Co-D Therapeutics is .

  • How much funding has Co-D Therapeutics raised over time?

    Co-D Therapeutics has raised $428K.

  • Who are Co-D Therapeutics’s investors?

    Wisconsin Economic Development, gBETA, and WARF Ventures have invested in Co-D Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »